Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Discover Oncology
|
May 5, 2026
Case report of adult-type diffuse high-grade glioma IDH-wildtype subtype E with secondary spinal leptomeningeal dissemination, prolonged survival and literature review
Adèle Meola, Romain Appay, Benoit Testud, et al.
Neuro-Oncology Advances
|
July 10, 2020
Brief CommunicationCirculating tumor DNA is present in the most aggressive meningiomas
Thomas Graillon, Catherine Roche, Noémie Basset, et al.
Neuro-Oncology Practice
|
November 27, 2023
Radio-chemotherapy feasibility for biopsy-only unresectable <i>IDH</i> wild-type glioblastomas (BO-GBM)
Vincent Harlay, Romain Appay, Céline Bequet, et al.
Journal of Neuro-Oncology
|
October 16, 2025
Autonomy duration in patients with biopsy-only unresectable IDH wild-type glioblastomas
Vincent Harlay, Céline Bequet, Romain Appay, et al.
International Journal of Molecular Sciences
|
July 24, 2021
Somatotroph Tumors and the Epigenetic Status of the <i>GNAS</i> Locus
Pauline Romanet, Justine Galluso, Peter Kamenicky, et al.
Journal of the Neurological Sciences
|
March 8, 2022
Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy
Brice Chanez, Romain Appay, Arnaud Guille, et al.
Neuro-Oncology
|
March 7, 2024
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
Emeline Tabouret, Julia Furtner, Thomas Graillon, et al.
Acta Neuropathologica Communications
|
January 4, 2022
Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study
Carine Jiguet-Jiglaire, Sebastien Boissonneau, Emilie Denicolai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 30, 2020
Somatostatin Receptor-Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis
Christian Mirian, Anne Katrine Duun-Henriksen, Andrea Maier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2020
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial
Thomas Graillon, Marc Sanson, Chantal Campello, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Discover Oncology
|
May 5, 2026
Case report of adult-type diffuse high-grade glioma IDH-wildtype subtype E with secondary spinal leptomeningeal dissemination, prolonged survival and literature review
Adèle Meola, Romain Appay, Benoit Testud, et al.
Neuro-Oncology Advances
|
July 10, 2020
Brief CommunicationCirculating tumor DNA is present in the most aggressive meningiomas
Thomas Graillon, Catherine Roche, Noémie Basset, et al.
Neuro-Oncology Practice
|
November 27, 2023
Radio-chemotherapy feasibility for biopsy-only unresectable <i>IDH</i> wild-type glioblastomas (BO-GBM)
Vincent Harlay, Romain Appay, Céline Bequet, et al.
Journal of Neuro-Oncology
|
October 16, 2025
Autonomy duration in patients with biopsy-only unresectable IDH wild-type glioblastomas
Vincent Harlay, Céline Bequet, Romain Appay, et al.
International Journal of Molecular Sciences
|
July 24, 2021
Somatotroph Tumors and the Epigenetic Status of the <i>GNAS</i> Locus
Pauline Romanet, Justine Galluso, Peter Kamenicky, et al.
Journal of the Neurological Sciences
|
March 8, 2022
Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy
Brice Chanez, Romain Appay, Arnaud Guille, et al.
Neuro-Oncology
|
March 7, 2024
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
Emeline Tabouret, Julia Furtner, Thomas Graillon, et al.
Acta Neuropathologica Communications
|
January 4, 2022
Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study
Carine Jiguet-Jiglaire, Sebastien Boissonneau, Emilie Denicolai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 30, 2020
Somatostatin Receptor-Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis
Christian Mirian, Anne Katrine Duun-Henriksen, Andrea Maier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2020
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial
Thomas Graillon, Marc Sanson, Chantal Campello, et al.
Page
of 11